Meta Pixel

News and Announcements

Mastering the Timing of Your Capital Raise: Key Elements to Consider

  • Published June 09, 2023 11:00PM UTC
  • Publisher Wholesale Investor
  • Categories Capital Raising Tips

Timing is a critical factor when it comes to raising capital for your business. The question is, how do you know when it’s the right time to start your capital raise? As a founder, you’re already juggling multiple responsibilities, and adding a capital raise to the mix can be overwhelming.

We understand how frustrating it can be to figure out the perfect timing and process for your capital raise. That’s why we’ve broken it down into three simple elements that can assist you. In this video, we provide you with a step-by-step guide on how to time your capital raise, so you can focus on growing your business without the added stress.

YouTube player

Don’t let the timing of your capital raise hold you back from achieving your business goals. Join us and learn how to get your timing right and take your business to the next level.

Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck

Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now